Associations of Systolic Blood Pressure and Diastolic Blood Pressure With the Incidence of Coronary Artery Disease or Cerebrovascular Disease According to Glucose Status.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
09 2021
Historique:
received: 09 09 2020
accepted: 02 04 2021
pubmed: 27 5 2021
medline: 21 10 2021
entrez: 26 5 2021
Statut: ppublish

Résumé

To determine associations of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with new-onset coronary artery disease (CAD) or cerebrovascular disease (CVD) according to glucose status. Examined was a nationwide claims database from 2008 to 2016 on 593,196 individuals. A Cox proportional hazards model identified risks of CAD and CVD events among five levels of SBP and DBP. During the study period 2,240 CAD and 3,207 CVD events occurred. Compared with SBP ≤119 mmHg, which was the lowest quintile of SBP, hazard ratios (95% CI) for CAD/CVD in the 4 higher quintiles (120-129, 130-139, 140-149, ≥150 mmHg) gradually increased from 2.10 (1.73-2.56)/1.46 (1.27-1.68) in quintile 2 to 3.21 (2.37-4.34)/4.76 (3.94-5.75) in quintile 5 for normoglycemia, from 1.39 (1.14-1.69)/1.70 (1.44-2.01) in quintile 2 to 2.52 (1.95-3.26)/4.12 (3.38-5.02) in quintile 5 for borderline glycemia, and from 1.50 (1.19-1.90)/1.72 (1.31-2.26) in quintile 2 to 2.52 (1.95-3.26)/3.54 (2.66-4.70) in quintile 5 for diabetes. A similar trend was observed for DBP across 4 quintiles (75-79, 80-84, 85-89, and ≥90 mmHg) compared with ≥74 mmHg, which was the lowest quintile. Results indicated that cardiovascular risks gradually increased with increases in SBP and DBP regardless of the presence of and degree of a glucose abnormality. Further interventional trials are required to apply findings from this cohort study to clinical practice.

Identifiants

pubmed: 34035075
pii: dc20-2252
doi: 10.2337/dc20-2252
doi:

Substances chimiques

Glucose IY9XDZ35W2

Banques de données

figshare
['10.2337/figshare.14368454']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2124-2131

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 by the American Diabetes Association.

Auteurs

Mayuko Harada Yamada (MH)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.
Division of Diabetes and Endocrinology and Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Kazuya Fujihara (K)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan kafujihara-dm@umin.ac.jp.

Satoru Kodama (S)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Takaaki Sato (T)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Taeko Osawa (T)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Yuta Yaguchi (Y)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Masahiko Yamamoto (M)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Masaru Kitazawa (M)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Yasuhiro Matsubayashi (Y)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Takaho Yamada (T)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Hiroyasu Seida (H)

JMDC Inc., Tokyo, Japan.

Wataru Ogawa (W)

Division of Diabetes and Endocrinology and Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.

Hirohito Sone (H)

Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH